Has Edward Skol, MD received payments from drug or device companies?

Yes. Drug and device makers reported $514 in general payments to Edward Skol, MD across 16 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Edward Skol, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Edward Skol, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Edward Skol, MD

Rheumatology · la Jolla, CANPI 1255304630

Payments from drug & device makers

$514in general payments, 2019–2025

Across 16 payments — averaging $32.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$389
AstraZeneca$125

What the payments were for

Food & beverage$514100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	15	$389
AstraZeneca	1	$125

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SAPHNELO$125

How this compares

$514 in reported general payments places this provider in the 30th percentile of 808 rheumatology providers in California.

See all rheumatology providers in California →

Medicare billing

Part B allowed, 2024

$2,467,491

Medicare patients

781

Services billed

126,735

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Enbrel SureclickEtanercept	33	$337,820
EnbrelEtanercept	21	$146,496
Gamunex-CImmune Globul G/Gly/Iga Avg 46	13	$114,818
Orencia ClickjectAbatacept	16	$89,130
ProliaDenosumab	24	$38,367
Teriparatide	12	$27,267
RasuvoMethotrexate/Pf	19	$13,445
MethotrexateMethotrexate Sodium	234	$9,558
Hydroxychloroquine Sulfate	73	$3,379
Colchicine	27	$3,192
Celecoxib	76	$3,067
Azathioprine	31	$3,005
Prednisone	266	$2,196
Leflunomide	37	$1,978
Alendronate Sodium	165	$1,616

Paid to pharmacies, not to this prescriber.

Other rheumatology in la Jolla

Arthur Kavanaughla Jolla$1.1M
Monica Gumala Jolla$720K
Dennis Carsonla Jolla$383K
Samy MetyasCovina$12.9M
Christine ThaiHuntington Beach$8.5M
Tien-I SuWhittier$8.4M
Eric LeeUpland$6.9M
Orrin TroumSanta Monica$6.9M
Shirley PangFullerton$5.7M
William RobinsonStanford$5.1M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →